Immuneering ($IMRX) Insider Trading & Smart Money Activity
Immuneering Corporation ($IMRX) has 3 insider trades on file. In the last 12 months on the open market, 2 insiders bought ($61.03K) and no insider sold, net +$61.03K.
- Insider buyers (12 mo)
- 2
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- +$61.03K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
IMRX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 3 · $61.03K | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All IMRX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Benjamin ZeskindPRESIDENT AND CEO | Buy (Open-market buy) | 2.40K sh | $10.94K | — | ||||||
| Insider | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Buy (Open-market buy) | 6.04K sh | $25.05K | — | ||||||
| Insider | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Buy (Open-market buy) | 6.04K sh | $25.05K | — |
1W / 1M / 6M = how IMRX moved from the trade or filing date.
Insider trading in IMRX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Benjamin Zeskind | PRESIDENT AND CEO | 1 | +$10.94K | Jun 23, 2026 | |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 2 | +$50.09K | Jun 15, 2026 |
Frequently asked questions
Are IMRX insiders buying or selling?
Over the last 12 months 2 insiders made 3 open-market purchases worth $61.03K and 0 insiders made 0 open-market sales worth $0, a net +$61.03K.
What is the latest insider trade in IMRX?
Benjamin Zeskind, PRESIDENT AND CEO filed a buy (open-market buy) of 2.40K sh worth $10.94K on Jun 23, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.